sisomicin has been researched along with Escherichia coli Infections in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (76.47) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Clabots, C; Johnson, JR; Johnston, BD; Porter, SB; Thuras, P | 1 |
| Attwood, M; Bowker, KE; Kim, A; Krause, KM; MacGowan, AP; Noel, AR | 1 |
| Babu, E; Bäcker, M; Bratu, S; Kelly, P; Landman, D; Quale, J; Shah, N | 1 |
| Argyropoulou, A; Chrysouli, Z; Daikos, GL; Galani, I; Giamarellou, H; Panagea, T; Petrikkos, G; Plakias, G; Poulakou, G; Psichogiou, M; Souli, M; Stefanou, I | 1 |
| Bassetti, D; Gallo, D; Navone, C; Serra, G; Viscoli, C | 1 |
| Dzierzanowska, D; Jeljaszewicz, J | 1 |
| Dzierzanowska, D; Jeljaszewicz, J; Klosinska, E; Patzer, J; Roszkowski, W | 1 |
| Coppens, L; Klastersky, J; Sculier, JP | 1 |
| Bis, W; Jeljaszewicz, J; Kazanowski, A; Kuzniewski, P; Molska, J; Włodarczak, K | 1 |
| Lirussi, F; Martines, D; Nassuato, G; Okolicsanyi, L; Orlando, R; Venuti, M | 1 |
| Orlowski, T; Stepka, L; Weuta, H | 1 |
| Mandaleris, CD; Sande, MA; Strausbaugh, LJ | 1 |
| Brown, RS; Sande, MA; Scheld, WM | 1 |
| Carpentier-Meunier, F; Kahan-Coppens, L; Klastersky, J; Thys, JP | 1 |
| Burchardt, U; Patsch, R; Richter, I; Sitka, U; Weingärtner, L | 1 |
| Lüthy, R | 1 |
| Firsov, AA | 1 |
1 review(s) available for sisomicin and Escherichia coli Infections
| Article | Year |
|---|---|
[Aminoglycoside antibiotics from clinical viewpoint].
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Drug Combinations; Enterobacteriaceae Infections; Escherichia coli Infections; Gentamicins; Glomerular Filtration Rate; Kanamycin; Klebsiella Infections; Proteus Infections; Providencia; Pseudomonas Infections; Serratia; Sisomicin; Streptomycin; Tobramycin | 1975 |
1 trial(s) available for sisomicin and Escherichia coli Infections
| Article | Year |
|---|---|
Endotracheally administered antibiotics for gram-negative bronchopneumonia.
Topics: Bacterial Infections; Bronchi; Bronchopneumonia; Carbenicillin; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Escherichia coli Infections; Gentamicins; Humans; Injections, Intravenous; Intubation, Intratracheal; Klebsiella Infections; Placebos; Proteus Infections; Pseudomonas Infections; Sisomicin; Tracheotomy | 1979 |
15 other study(ies) available for sisomicin and Escherichia coli Infections
| Article | Year |
|---|---|
Comparative activity of plazomicin against extended-spectrum cephalosporin-resistant Escherichia coli clinical isolates (2012-2017) in relation to phylogenetic background, sequence type 131 subclones, bla
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Genotype; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Phylogeny; Sisomicin; Young Adult | 2021 |
Pharmacodynamics of plazomicin and a comparator aminoglycoside, amikacin, studied in an in vitro pharmacokinetic model of infection.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Load; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sisomicin | 2019 |
Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York City.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; New York City; Polymerase Chain Reaction; Sequence Analysis, DNA; Sisomicin; tRNA Methyltransferases | 2010 |
Activity of plazomicin (ACHN-490) against MDR clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Enterobacter spp. from Athens, Greece.
Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Enterobacter; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Gentamicins; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sisomicin; Tertiary Care Centers; Tobramycin | 2012 |
[Sisomicin in infections of the newborn].
Topics: Bacterial Infections; Enterobacteriaceae Infections; Escherichia coli Infections; Humans; Infant, Newborn; Klebsiella Infections; Sisomicin; Staphylococcal Infections; Streptococcal Infections; Urinary Tract Infections | 1984 |
In vitro and in vivo action of mezlocillin and azlocillin combined with sisomicin.
Topics: Animals; Azlocillin; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Escherichia coli; Escherichia coli Infections; Klebsiella Infections; Klebsiella pneumoniae; Mezlocillin; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Sisomicin | 1983 |
Evaluation of therapeutic efficacy of ureidopenicillins in comparison to sisomicin and cephalotin in experimental infections of rabbits.
Topics: Animals; Azlocillin; Cephalothin; Drug Evaluation, Preclinical; Escherichia coli Infections; Klebsiella Infections; Klebsiella pneumoniae; Mezlocillin; Penicillins; Pseudomonas Infections; Rabbits; Sisomicin | 1981 |
Effectiveness of mezlocillin and endotracheally administered sisomicin with or without parenteral sisomicin in the treatment of Gram-negative bronchopneumonia.
Topics: Adult; Aged; Bronchopneumonia; Drug Therapy, Combination; Enterobacteriaceae Infections; Escherichia coli Infections; Gentamicins; Humans; Klebsiella Infections; Mezlocillin; Middle Aged; Penicillins; Proteus Infections; Pseudomonas Infections; Sisomicin | 1982 |
Experimental infection in rabbits evoked by Pseudomonas aeruginosa, Proteus mirabilis, Escherichia coli and Klebsiella pneumoniae treated with gentamicin, amikacin and sisomicin.
Topics: Amikacin; Animals; Enterobacteriaceae Infections; Escherichia coli Infections; Gentamicins; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Proteus Infections; Proteus mirabilis; Pseudomonas Infections; Rabbits; Sisomicin | 1980 |
[Therapeutic effectiveness of metossimine associated with an aminoglycoside in a case of severe gram-negative sepsis].
Topics: Cefuroxime; Cephalosporins; Diabetes Complications; Drug Therapy, Combination; Escherichia coli Infections; Gastrointestinal Diseases; Gentamicins; Humans; Male; Middle Aged; Paromomycin; Proteus Infections; Sisomicin | 1981 |
[The treatment of bacterial infections in surgery with sisomicin].
Topics: Adult; Aged; Drug Administration Schedule; Drug Evaluation; Escherichia coli Infections; Evaluation Studies as Topic; Female; Gentamicins; Humans; Male; Middle Aged; Proteus Infections; Pseudomonas Infections; Sisomicin; Staphylococcal Infections; Surgical Wound Infection | 1979 |
Comparison of four aminoglycoside antibiotics in the therapy of experimental E. coli meningitis.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Escherichia coli; Escherichia coli Infections; Gentamicins; Kanamycin; Meningitis; Rabbits; Sisomicin; Tobramycin | 1977 |
Comparison of netilmicin with gentamicin in the therapy of experimental Escherichia coli meningitis.
Topics: Animals; Escherichia coli Infections; Gentamicins; Meningitis; Rabbits; Sisomicin | 1978 |
[Experience with sisomicin in pediatrics (author's transl)].
Topics: Age Factors; Bacterial Infections; Citrobacter; Enterobacter; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Gentamicins; Humans; Infant; Infant, Newborn; Klebsiella Infections; Male; Proteus Infections; Pseudomonas Infections; Salmonella Infections; Serratia; Sisomicin; Staphylococcal Infections | 1979 |
[Correlation of dose-antimicrobial effect in modeling in vitro pharmacokinetic profiles of normal and impaired elimination of antibiotics].
Topics: Cefotaxime; Dose-Response Relationship, Drug; Escherichia coli; Escherichia coli Infections; Humans; In Vitro Techniques; Metabolic Clearance Rate; Sisomicin | 1989 |